The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Omeflex peri emulsion for infusion


Emulsion for infusion


B. Braun Melsungen AGPA0736/033/002

Main Information

Trade NameOmeflex peri emulsion for infusion
Active SubstancesIsoleucine
Leucine
Lysine hydrochloride
Methionine
Phenylalanine
Threonine
Tryptophan
Valine
Arginine
Histidine hyprochloride monohydrate
Alanine
Aspartic acid
Glutamic acid
Glycine
Proline
Serine
Sodium hydroxide
Sodium chloride
Sodium acetate trihydrate
Potassium acetate
Magnesium acetate tetrahydrate
Calcium chloride dihydrate
Glucose monohydrate
Sodium dihydrogen phosphate dihydrate
Zinc acetate dihydrate
Triglycerides, medium chain
Soya bean oil, refined
Omega-3-acid triglycerides
Strength
Dosage FormEmulsion for infusion
Licence HolderB. Braun Melsungen AG
Licence NumberPA0736/033/002

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA10 combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued10/02/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back